Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
| Revenue (TTM) | $20.61B |
| Gross Profit (TTM) | $14.21B |
| EBITDA | $5.50B |
| Operating Margin | 20.60% |
| Return on Equity | 14.70% |
| Return on Assets | 6.07% |
| Revenue/Share (TTM) | $13.91 |
| Book Value | $17.40 |
| Price-to-Book | 3.32 |
| Price-to-Sales (TTM) | 4.17 |
| EV/Revenue | 4.631 |
| EV/EBITDA | 17.38 |
| Quarterly Earnings Growth (YoY) | 100.00% |
| Quarterly Revenue Growth (YoY) | 11.60% |
| Shares Outstanding | $1.49B |
| Float | $1.48B |
| % Insiders | 0.23% |
| % Institutions | 94.92% |
Volatility is currently contracting